Nigeria begins delayed mpox vaccination programme
November 18, 2024
Nigeria launched its mpox vaccination campaign, targeting health workers and immunocompromised individuals, such as people living with HIV, in Abuja and seven other states. The country received 10,000 doses from the U.S. after the WHO declared mpox a global health emergency. With 94 confirmed cases but no deaths reported this year, Nigeria’s approach focuses on targeted "ring" vaccinations rather than mass campaigns. This 10-day initiative highlights the importance of protecting vulnerable groups and frontline workers in regions with endemic mpox. As Africa continues its vaccination efforts, 899,000 doses have been allocated for nine of the hardest-hit countries.
Nigeria has commenced its mpox vaccination campaign, focusing on health workers and immunocompromised individuals, including those living with HIV. At the Federal Medical Centre in Abuja, 30 people received shots on the first day, marking the launch of a 10-day targeted vaccination program. The campaign covers Abuja and seven other states, including oil-rich Akwa Ibom, Bayelsa, and Rivers, areas that have reported multiple mpox cases.
The initiative follows the arrival of 10,000 vaccine doses from the United States in August, shortly after the World Health Organization (WHO) declared mpox a global public health emergency for the second time in two years. While Nigeria has recorded 94 confirmed cases and no deaths this year, its targeted "ring" vaccination approach aims to curb transmission by focusing on the most vulnerable groups, rather than mass vaccination campaigns.
Hafsat Abdullazeez of the Institute of Human Virology in Abuja emphasized the importance of protecting healthcare workers and immunocompromised populations. This strategy aligns with efforts across Africa, where 899,000 vaccine doses have been allocated to nine of the hardest-hit countries, according to the WHO.
Hardley Ikwe of the U.S. CDC noted that Nigeria's program represents a critical step in safeguarding public health within regions where mpox remains endemic. As the continent grapples with rising infections, targeted vaccination programs like Nigeria’s are vital for preventing further spread while maximizing limited resources.
This campaign demonstrates the importance of international cooperation, with vaccine donations playing a crucial role in enhancing Africa’s capacity to respond to mpox outbreaks. By prioritizing vulnerable populations and frontline workers, Nigeria’s vaccination effort underscores a practical, focused approach to managing endemic diseases and protecting public health.